TRADUÇÃO E ADAPTAÇÃO TRANSCULTURAL DO INSTRUMENTO SELF CARE OF HEART FAILURE INDEX 6.2 PARA USO NO URUGUAI

Objetivo: traduzir e adaptar transculturalmente o instrumento Self-Care of Heart Failure Index 6.2para uso no Uruguai.Método: estudo metodológico, realizado em clínica de cuidados multidisciplinares em insuficiênciacardíaca no Uruguai entre novembro de 2016 e setembro de 2017. Foram desenvolvidas as etapas:tradução, síntese das versões traduzidas, retrotradução, avaliação pelo comitê de experts e préteste.Para análise, utilizou-se o índice de validade de conteúdo (adequado > 0,9), percentual deconcordância (adequado ≥ 80%) e o alfa de Cronbach no pré-teste (adequado ≥ 0,70).Resultado: na primeira avaliação, seis itens apresentaram IVC 0,9 e/oupercentual de concordâncias maior que 70%. A consistência interna da escala foi de0 ,78.Conclusão: a tradução e adaptação deste instrumento proporciona o desenvolvimento de estudosmulticêntricos por proporcionar as mesmas medidas de avaliação de desfechos.Objective: To translate and cross-culturally adapt the Self-Care of Heart Failure Index 6.2instrument for use in Uruguay.Method: A methodological study, performed at a multidisciplinary heart failure care clinic inUruguay between November 2016 and September 2017. The following stages were developed:translation, synthesis of translated versions, back-translation, expert committee evaluation andpre-test. For the analysis, the content validity index (adequate > 0.9), agreement percentage(adequate ≥ 80%) and Cronbach’s alpha in the pre-test (adequate ≥ 0.70) were used.Result: In the first evaluation, six items displayed CVI 0.9 and/or an agreement percentage greater than 70%. The internal consistency of the scalewas 0.78.Conclusion: The translation and adaptation of this instrument enables the development ofmulti-center studies by providing the same outcome assessment measures.Objetivo: traducir y adaptar transculturalmente el instrumento Self-Care of Heart Failure Index6.2 para su uso en Uruguay.Método: estudio metodológico, realizado en una clínica de cuidados multidisciplinarespara insuficiencias cardíacas de Uruguay entre noviembre de 2016 y septiembre de 2017.Se desarrollaron las siguientes etapas: síntesis de las versiones traducidas, retrotraducción,evaluación a cargo de un comité de expertos y prueba previa. Para el análisis, se utilizó elíndice de validez del contenido (adecuado > 0,9), el porcentaje de concordancia (adecuado ≥80%) y el coeficiente alfa de Cronbach en la prueba previa (adecuado ≥ 0,70).Resultado: en la primera evaluación, seis puntos presentaron un valor de IVC 0,9 y/o un porcentaje de concordancias superior al70%. La consistencia interna de la escala fue de 0,78.Conclusión: la traducción y adaptación de este instrumento proporciona la capacidadpara desarrollar estudios multicéntricos por ofrecer las mismas medidas de evaluación deresultados

Plan de acción estratégica 2015-2021 para la adaptación al cambio climático de comunidades campesinas ubicadas en centros de origen y diversificación de cultivos nativos sierra central y sur

El Plan de Acción Estratégica 2015-2021 tiene como objetivo general, integrar los intereses y visiones de las comunidades campesinas ubicadas en centros de origen y diversificación de cultivos nativos altoandinos y demás actores sociales clave, en el proceso de adaptación al cambio climático en la región altoandina. La estructura de este plan se planteó a partir de la revisión de la bibliografía, especialmente de experiencias previas como el Plan de Acción Estratégico para fortalecer la conservación y el uso de los recursos Fitogenéticos mesoamericanos para la adaptación de la agricultura al cambio climático -PAEM- (Bioversity International 2014), la Guía para la elaboración de estrategias regionales sobre Cambio Climático (MINAM 2011), el Plan de Acción de Adaptación y Mitigación (MINAM 2010), la experiencia de PACC Apurímac (PACCPERU y otros 2014), el Proyecto Manejo Sostenible de la Tierra MST Apurímac (MINAM 2011), entre otros y luego se definió a partir de los intereses y necesidades de las comunidades campesinas altoandinas sobre el cambio climático y la agrobiodiversidad

Cabbage and fermented vegetables : From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the angiotensin-converting enzyme 2 (ACE2). As a result of SARS-CoV-2 binding, ACE2 downregulation enhances the angiotensin II receptor type 1 (AT(1)R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the most potent antioxidant in humans and can block in particular the AT(1)R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance Nrf2-associated antioxidant effects, helpful in mitigating COVID-19 severity.Peer reviewe

Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies

There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPAR gamma:Peroxisome proliferator-activated receptor, NF kappa B: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2 alpha:Elongation initiation factor 2 alpha). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT(1)R axis (AT(1)R) pathway. Many Nrf2-interacting nutrients are also interacting with TRPA1 and/or TRPV1. Interestingly, geographical areas with very low COVID-19 mortality are those with the lowest prevalence of obesity (Sub-Saharan Africa and Asia). It is tempting to propose that Nrf2-interacting foods and nutrients can re-balance insulin resistance and have a significant effect on COVID-19 severity. It is therefore possible that the intake of these foods may restore an optimal natural balance for the Nrf2 pathway and may be of interest in the mitigation of COVID-19 severity

Impact of common cardio-metabolic risk factors on fatal and non-fatal cardiovascular disease in Latin America and the Caribbean: an individual-level pooled analysis of 31 cohort studies

Background: Estimates of the burden of cardio-metabolic risk factors in Latin America and the Caribbean (LAC) rely on relative risks (RRs) from non-LAC countries. Whether these RRs apply to LAC remains un- known. Methods: We pooled LAC cohorts. We estimated RRs per unit of exposure to body mass index (BMI), systolic blood pressure (SBP), fasting plasma glucose (FPG), total cholesterol (TC) and non-HDL cholesterol on fatal (31 cohorts, n = 168,287) and non-fatal (13 cohorts, n = 27,554) cardiovascular diseases, adjusting for regression dilution bias. We used these RRs and national data on mean risk factor levels to estimate the number of cardiovascular deaths attributable to non-optimal levels of each risk factor. Results: Our RRs for SBP, FPG and TC were like those observed in cohorts conducted in high-income countries; however, for BMI, our RRs were consistently smaller in people below 75 years of age. Across risk factors, we observed smaller RRs among older ages. Non-optimal SBP was responsible for the largest number of attributable cardiovascular deaths ranging from 38 per 10 0,0 0 0 women and 54 men in Peru, to 261 (Dominica, women) and 282 (Guyana, men). For non-HDL cholesterol, the lowest attributable rate was for women in Peru (21) and men in Guatemala (25), and the largest in men (158) and women (142) from Guyana. Interpretation: RRs for BMI from studies conducted in high-income countries may overestimate disease burden metrics in LAC; conversely, RRs for SBP, FPG and TC from LAC cohorts are similar to those esti- mated from cohorts in high-income countries

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Efeito da entrevista motivacional no autocuidado de pessoas com insuficiência cardíaca: ensaio clínico randomizado

Objective: To analyze the effect of motivational interviewing on self-care for people with chronic heart failure. Method: A multicenter randomized clinical trial, which divided people into an intervention group (n=59) and a control group (n=59), followed for 60 days in centers of Brazil and Uruguay. The intervention group received three consultations per motivational interviewing, with an interval of 30 days, and the control group maintained conventional follow-up in specialized clinics. The data were assessed using the Self-Care of Heart Failure Index 6.2, before and after intervention in each of the centers. They were analyzed using the mean, median, t-test, correlation analysis using the Spearman coefficient and effect of the intervention by Cohen’s d. Results: One hundred and eighteen people completed the study. In view of the assessment of the effect of the motivational interviewing on self-care, compared to conventional follow-up, a medium effect on maintenance and management (Cohen’s d=0.6723; 0.5086) and high on self-care confidence (Cohen’s d=0.9877). Conclusion: Motivational interviewing was effective in improving self-care in patients with heart failure, being a feasible strategy to be implemented in specialized clinics. Brazilian Registry of Clinical Trials (Registro Brasileiro de Ensaios Clínicos): RBR-6fp5qt.Objetivo: Analisar o efeito da entrevista motivacional no autocuidado de pessoas com insuficiência cardíaca crônica. Método: Ensaio clínico randomizado, multicêntrico, dividindo as pessoas em grupo intervenção (n=59) e grupo controle (n=59), acompanhadas por 60 dias nos centros do Brasil e Uruguai. O grupo intervenção recebeu três consultas por entrevista motivacional, com intervalo de 30 dias, e o grupo controle manteve o acompanhamento convencional nas clínicas especializadas. Os dados foram avaliados através do Self-Care of Heart Failure Index 6.2, antes e após a intervenção, em cada um dos centros e analisados através de média, mediana, teste-t, análise de correlação pelo coeficiente de Spearman e efeito da intervenção pelo d de Cohen. Resultados: 118 pessoas concluíram o estudo. Diante da avaliação do efeito da entrevista motivacional no autocuidado, comparando-se ao acompanhamento convencional, foi identificado efeito médio na manutenção e manejo (Cohen-d=0,6723; 0,5086) e alto na confiança do autocuidado (Cohen-d=0,9877). Conclusão: A entrevista motivacional foi efetiva na melhora do autocuidado dos pacientes com insuficiência cardíaca, sendo uma estratégia factível a ser implementada em clínicas especializadas. Registro Brasileiro de Ensaios Clínicos: RBR-6fp5qt.Ensayo clínico aleatorizado, multicéntrico, que divide a las personas en un grupo de intervención (n=59) y un grupo de control (n=59), seguidos durante 60 días en centros de Brasil y Uruguay. El grupo de intervención recibió tres consultas por entrevista motivacional, con un intervalo de 30 días, y el grupo de control mantuvo el monitoreo convencional en clínicas especializadas. Los datos se evaluaron utilizando el Self-Care of Heart Failure Index 6.2, antes y después de la intervención, en cada uno de los centros y se analizaron utilizando la media, la mediana, la prueba t, el análisis de correlación utilizando el coeficiente de Spearman y el efecto de la intervención por el d de Cohen. Resultados: 118 personas completaron el estudio. En vista de la evaluación del efecto de la entrevista motivacional sobre el autocuidado, en comparación con el seguimiento convencional, un efecto medio en el mantenimiento y el manejo (Cohen-d=0.6723; 0.5086) y alto en la confianza en el autocuidado (Cohen-d=0,9877). Conclusión: La entrevista motivacional fue efectiva para mejorar el autocuidado de pacientes con insuficiencia cardíaca, siendo una estrategia factible para ser implementada en clínicas especializadas. Registro brasileño de ensayos clínicos: RBR-6fp5qt

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

Background Results from retrospective studies suggest that use of neuromuscular blocking agents during general anaesthesia might be linked to postoperative pulmonary complications. We therefore aimed to assess whether the use of neuromuscular blocking agents is associated with postoperative pulmonary complications. Methods We did a multicentre, prospective observational cohort study. Patients were recruited from 211 hospitals in 28 European countries. We included patients (aged ≥18 years) who received general anaesthesia for any in-hospital procedure except cardiac surgery. Patient characteristics, surgical and anaesthetic details, and chart review at discharge were prospectively collected over 2 weeks. Additionally, each patient underwent postoperative physical examination within 3 days of surgery to check for adverse pulmonary events. The study outcome was the incidence of postoperative pulmonary complications from the end of surgery up to postoperative day 28. Logistic regression analyses were adjusted for surgical factors and patients’ preoperative physical status, providing adjusted odds ratios (ORadj) and adjusted absolute risk reduction (ARRadj). This study is registered with ClinicalTrials.gov, number NCT01865513. Findings Between June 16, 2014, and April 29, 2015, data from 22803 patients were collected. The use of neuromuscular blocking agents was associated with an increased incidence of postoperative pulmonary complications in patients who had undergone general anaesthesia (1658 [7·6%] of 21694); ORadj 1·86, 95% CI 1·53–2·26; ARRadj –4·4%, 95% CI –5·5 to –3·2). Only 2·3% of high-risk surgical patients and those with adverse respiratory profiles were anaesthetised without neuromuscular blocking agents. The use of neuromuscular monitoring (ORadj 1·31, 95% CI 1·15–1·49; ARRadj –2·6%, 95% CI –3·9 to –1·4) and the administration of reversal agents (1·23, 1·07–1·41; –1·9%, –3·2 to –0·7) were not associated with a decreased risk of postoperative pulmonary complications. Neither the choice of sugammadex instead of neostigmine for reversal (ORadj 1·03, 95% CI 0·85–1·25; ARRadj –0·3%, 95% CI –2·4 to 1·5) nor extubation at a train-of-four ratio of 0·9 or more (1·03, 0·82–1·31; –0·4%, –3·5 to 2·2) was associated with better pulmonary outcomes. Interpretation We showed that the use of neuromuscular blocking drugs in general anaesthesia is associated with an increased risk of postoperative pulmonary complications. Anaesthetists must balance the potential benefits of neuromuscular blockade against the increased risk of postoperative pulmonary complications